#wvcusa recent advances for Meningococcal vaccine by Dr Peter Dull @Novartis Vaccines

  Meningococcal vaccine: Dr Peter Dull, Head Development Meningococcal Vaccines at Novartis Vaccines and Diagnostics delivered an interested presentation last week at the World Vaccine Congress about the recent advances on Meningococcal vaccine. Some Key points raised in the presentation: Dr Dull  mentioned that the company goal was to design a broadly protective Meningococcal B vaccine. The capsule of Men …